Fatty acid desaturase 1 drives esophageal cancer via M1 macrophage ferroptosis and lipid metabolism remodeling

Figure 10  Artificial intelligence-assisted drug screening and molecular docking analysis of fatty acid desaturase 1-targeting compounds. A: Distribution of logit scores and probabilities for drugs predicted to reverse the esophageal cancer transcriptional signature by the DrugReflector model, highlighting the top 10 candidate drugs with the highest reversal scores; B: Molecular docking analysis showing the binding mode of BRD-K95779464 with the fatty acid desaturase 1 protein (left: Overall binding conformation; right: Close-up view displaying key contact residues).